APA (7th ed.) Citation

Baxi, S. M., Clemenzi-Allen, A., Gahbauer, A., Deck, D., Imp, B., Vittinghoff, E., . . . Doernberg, S. (2016). Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia. Antimicrobial agents and chemotherapy, 60(9), 5276-5284. https://doi.org/10.1128/AAC.00658-16

Chicago Style (17th ed.) Citation

Baxi, Sanjiv M., Angelo Clemenzi-Allen, Alice Gahbauer, Daniel Deck, Brandon Imp, Eric Vittinghoff, Henry F. Chambers, and Sarah Doernberg. "Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus Aureus Bacteremia." Antimicrobial Agents and Chemotherapy 60, no. 9 (2016): 5276-5284. https://doi.org/10.1128/AAC.00658-16.

MLA (9th ed.) Citation

Baxi, Sanjiv M., et al. "Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus Aureus Bacteremia." Antimicrobial Agents and Chemotherapy, vol. 60, no. 9, 2016, pp. 5276-5284, https://doi.org/10.1128/AAC.00658-16.